Wanda partners with Dignity Health to launch OncoVerse to deliver advanced oncology decision support

Software provides oncologists and cancer patients with decision support and collaboration capabilities using Wanda's digital health platform

Feb 29, 2016, 02:00 ET from Wanda

SAN FRANCISCO, Feb. 29, 2016 /PRNewswire/ -- Wanda™, Inc. in partnership with Dignity Health, announced today the launch of the OncoVerse™ virtual care collaboration platform. OncoVerse is a digital health platform designed to enable the patient's care team to collaborate in real-time and allow clinicians across all disciplines to work together to determine the most effective treatment plan for cancer patients.

"We are thrilled to partner with Dignity Health to launch the OncoVerse product," said Steve Curd, CEO of Wanda. "OncoVerse will streamline and support the decision making processes of Dignity Health's physicians and other supporting health care professionals by ensuring that the entire care team has the right information at the right time, which reinforces the power of personalized medicine. As cancer therapies continue to advance, facilitating individualized cancer decision support is well-aligned with Wanda's mission: improving the efficiency and effectiveness of the management of chronic conditions."

OncoVerse was initially conceived by a Dignity Health physician who wanted a tool to improve team collaboration, especially when evaluating a complex cancer case and determining the appropriate treatment plan. Dignity Health engaged Wanda to develop the software due to the company's proven track record to support informed treatment decisions, and to reduce administrative costs.

"Dignity Health is committed to developing partnerships that harness the tremendous potential of technology to help providers and patients make better day-to-day decisions about care," said Costanzo DiPerna, MD, Medical Director for the Dignity Health Cancer Institute of the Greater Sacramento Region and Chief of Thoracic Surgery. "We are excited to work with Wanda and deliver on our vision to provide the highest quality patient care."

OncoVerse enables unprecedented information-sharing capabilities through geographically dispersed, structured collaboration of the multidisciplinary care team in real-time. Dignity Health can now expand the reach of its best available clinical decision-making support through OncoVerse to rural and remote areas, enabling patients in those locations to benefit from insights previously only shared at large medical centers.  Wanda and Dignity Health intend to jointly market the Oncoverse platform available to other oncology programs across the U.S. later in 2016.

About OncoVerse

San Francisco-based Oncoverse, LLC is a digital health care platform company which enables health care professionals to collaborate on cancer patient care decisions, and to monitor the progress of patient therapies.  OncoverseTM has the potential to transform cancer care delivery by establishing a common platform for all cancer patients to access the best medical expertise, while at the same time providing physicians with an opportunity to present their oncology cases for evidence-based peer collaboration, review, treatment recommendations and second opinions that are available 24/7 from any computer or other web-enabled device.

About Dignity Health

Dignity Health, one of the nation's largest health care systems, is a 21-state network of nearly 9,000 physicians, 59,000 employees, and more than 400 care centers, including hospitals, urgent and occupational care, imaging centers, home health, and primary care clinics. Headquartered in San Francisco, Dignity Health is dedicated to providing compassionate, high-quality and affordable patient-centered care with special attention to the poor and underserved. In FY15, Dignity Health provided $1.7 billion in charitable care and services. For more information, please visit our website at www.dignityhealth.org. You can also follow us on Twitter and Facebook.

About Wanda

San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company.  More information about Wanda can be found HERE.

Media Contact: 

Wanda Contact:

Michelle Noteboom 

Mark Heinemeyer

Amendola Communications for Wanda 

Chief Collaboration Officer





Logo - http://photos.prnewswire.com/prnh/20160113/322054LOGO